RMR Wealth Builders’s Filana Therapeutics FLNA Stock Holding History

RMR Wealth Builders’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,000	Closed	-$3K	–	424
2020 Q2	$3K	Buy	+1,000	New	+$4.54K	﹤0.01%	403

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

RMR Wealth Builders's FLNA Position: Q3 2020 in Review

RMR Wealth Builders sold out of Filana Therapeutics (FLNA) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

RMR Wealth Builders first reported a position in FLNA in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 68 funds tracked by Wall St. Rank hold FLNA as of Q3 2020.

RMR Wealth Builders reported no remaining Filana Therapeutics position as of Q3 2020 after selling out during the quarter.
RMR Wealth Builders sold 1,000 Filana Therapeutics shares in Q3 2020, an estimated $3K.
RMR Wealth Builders first reported a position in Filana Therapeutics in Q2 2020 and held it in 1 quarter.
RMR Wealth Builders's Filana Therapeutics position peaked at $3K in Q2 2020.
68 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2020.

Based on RMR Wealth Builders's 13F filing for Q3 2020, filed 13 Nov 2020.